Recursion Pharmaceuticals Inc Clas (RXRX)
EBITDA Margin
-810.22%
TTM · Period ending:
RXRX EBITDA Margin
Latest reported-810.22%period ending
Latest reported-810.22%period ending
RXRX TTM EBITDA Margin (-2379.29% → -810.22%)
TTM ebitda margin
High-resolution chart · PNG
RXRX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -810.2197% | |
| -723.3345% | |
| -751.3378% | |
| -1,463.0496% | |
| -905.6982% | |
| -878.4005% | |
| -729.5907% | |
| -543.117% | |
| -716.4579% | |
| -731.3377% | |
| -701.1373% | |
| -580.4999% | |
| -490.078% | |
| -507.4555% | |
| -573.7406% | |
| -828.3354% | |
| -1,244.6858% | |
| -1,556.8013% | |
| -1,751.23% | |
| -1,356.2631% | |
| -1,356.9595% | |
| -1,574.2432% | |
| -2,379.2851% |